NeonMind Bioscience Inc.
NeonMind Bioscience Inc.
Indice CSE:
Devise:
The Issuer is engaged in drug development of psychedelic compounds with two lead psilocybin-based drug candidates targeting obesity.
NeonMind Bioscience Inc. (NEON)
SEDAR Information
Information d'entreprise
Addresse
1489 Marine Drive
Unit 546
West Vancouver, BC V7T 1B8
CanadaTéléphone
1 866-811-8960Courriel
info@neonmind.comURL
http://www.neonmind.comDate d’inscription à la cote
Lundi, janvier 4, 2021
Agent de transfert
Endeavor Trust CorporationVérificateur
Saturna Group Chartered Professional Accountants LLPCapitalisation
Capitalisation:
1,123,404Réservé à l'émission:
271,031Communiqués de presse
Bulletins
02/03/2023
2023-0306 – Consolidation - NeonMind Biosciences Inc. (NEON)
le 2 mars/March 2023
NeonMind Biosciences Inc. (the Issuer), currently halted pending a fundamental change review pursuant to CSE Policy, has completed a share consolidation on the basis of one (1) post-consolidated common share for every thirty (30) pre-consolidated common shares.
Advertisement
Publicité
Évènements à venir
Benzinga Cannabis Capital Conference
Mardi, avril 11, 2023 - 08:00 - Mercredi, avril 12, 2023 - 17:00
